Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.000
-0.040 (-3.85%)
At close: Nov 13, 2026, 4:00 PM EST
1.040
+0.040 (4.00%)
After-hours: Nov 13, 2026, 7:31 PM EST
Cardiol Therapeutics Market Cap
Cardiol Therapeutics has a market cap or net worth of $120.5 million as of November 13, 2026. Its market cap has increased by 17.79% in one year.
Market Cap
120.50M
Enterprise Value
100.06M
1-Year Change
17.79%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since December 20, 2018, Cardiol Therapeutics's market cap has increased from $69.77M to $120.50M, an increase of 72.71%. That is a compound annual growth rate of 7.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 120.45M | 26.68% |
| Dec 31, 2025 | 95.08M | -9.38% |
| Dec 31, 2024 | 104.92M | 93.06% |
| Dec 29, 2023 | 54.35M | 67.34% |
| Dec 30, 2022 | 32.48M | -71.06% |
| Dec 31, 2021 | 112.23M | 56.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 204.07M |
| ADC Therapeutics | 199.74M |
| Anika Therapeutics | 179.75M |
| Akebia Therapeutics | 131.45M |
| Glass House Brands | 124.40M |
| Journey Medical | 121.08M |
| Organigram Global | 115.52M |
| Organogenesis Holdings | 109.03M |